High-precision Vericheck ddPCR Empty-Full Capsid Kit advances gene therapies

Using Bio-Rad’s Droplet Digital™ PCR technology, the new Vericheck ddPCR™ Empty-Full Capsid Kit analyzes minimal amounts of either crude lysate or purified samples to deliver robust, reproducible data for reliable assessment of AAV vector quality.

Designed for use on Bio-Rad’s Droplet Digital PCR Systems, the Kit’s cost-effective and accessible solution enables optimization of AAV vector characterization processes to streamline gene therapy development and production while supporting compliance with regulatory guidelines.

Stephen Kulisch, Vice President of Marketing for Bio-Rad’s Digital Biology Group, said, “Our new Vericheck ddPCR Empty-Full Capsid Kit delivers unmatched precision and specificity, along with ease of use and high-throughput capabilities, to provide our customers with a comprehensive solution for AAV vector characterization and to help drive the advancement of safe and effective gene therapies.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>